OMNIGENE INC has a total of 13 patent applications. Its first patent ever was published in 1985. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and machines are FROMMER WOLF B, GLYKOS FINLAND LTD and OXFORD NANOPORE TECHNOLOGIES L.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Machines | |
#4 | Foods and drinks | |
#5 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Analysing materials | |
#3 | Microorganisms | |
#4 | Unspecified technologies | |
#5 | Peptides | |
#6 | Preservation of human bodies | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Pero Janice | 6 |
#2 | Munkholm Christiane | 5 |
#3 | Sloma Alan | 5 |
#4 | Backman Keith C | 5 |
#5 | Rufo Jr Gerald A | 4 |
#6 | Sullivan Barbara J | 3 |
#7 | Yocum Robert Rogers | 2 |
#8 | Rudolph Cathy F | 2 |
#9 | Robbins Phillips W | 1 |
#10 | Rudolph Cathy Faye | 1 |
Publication | Filing date | Title |
---|---|---|
AU3145393A | Ligand assay using interference modulation | |
CA2149784A1 | Ligand assay using interference modulation | |
US5196350A | Ligand assay using interference modulation | |
US5294542A | Residual protease-III | |
US5188961A | DNA encoding a Streptomyces endochitinase 56 signal peptide | |
EP0316444A1 | Yeast expression vector |